Jiarui Yao
Shandong First Medical University(CN)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses, Advanced Biosensing Techniques and Applications, Glycosylation and Glycoproteins Research, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers(2007)273 cited
- → Functional Genetic Variations in Cytotoxic T-Lymphocyte Antigen 4 and Susceptibility to Multiple Types of Cancer(2008)158 cited
- → Safety and clinical efficacy of toripalimab, a PD-1 mAb, in patients with advanced or recurrent malignancies in a phase I study(2020)65 cited
- → Functional evaluation of missense variations in the human MAD1L1 and MAD2L1 genes and their impact on susceptibility to lung cancer(2010)48 cited
- → Antitumor Effects of a Novel Chromosome Region Maintenance 1 (CRM1) Inhibitor on Non-Small Cell Lung Cancer Cells In Vitro and in Mouse Tumor Xenografts(2014)42 cited
- → Spatial-temporal evolution law analysis of resource and environment carrying capacity based on game theory combination weighting and GMD-GRA-TOPSIS model. Evidence from 18 cities in Henan Province, China(2024)41 cited
- → Autoantibody profiling identifies predictive biomarkers of response to anti-PD1 therapy in cancer patients(2020)39 cited
- → Comparison of CBV, BEAM and BEAC high‐dose chemotherapy followed by autologous hematopoietic stem cell transplantation in non‐Hodgkin lymphoma: Efficacy and toxicity(2017)25 cited
- → Obesity and head and neck cancer risk: a mendelian randomization study(2023)24 cited
- → Interleukin-23 receptor genetic variants contribute to susceptibility of multiple cancers(2013)24 cited